Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

SAVASAVA
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in FILANA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 668,792 shares of SAVA (FILANA THERAPEUTICS INC), worth $795,862 as of 2026-Q2. The position was increased (+1518.4% shares). SAVA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$795,862

Current Shares

668,792

Total Value Change

+$137,637

Total Shares Change

+389,883

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
668,792
+1518.4%
$795,8620.0%$2.22
40
2026-Q1
Increased
41,324
+25.3%
$69,8380.0%$2.22
18
2025-Q4
Decreased
32,989
-93.0%
$65,3180.0%$2.03
0
2025-Q3
Decreased
472,860
-22.9%
$1.4M0.0%$3.14
0
2025-Q2
Increased
613,143
+23.5%
$1.1M0.0%$1.75
31
2025-Q1
Increased
496,313
+78.0%
$744,4700.0%$1.65
38
2024-Q4
New
278,909
-
$658,2250.0%$2.40
34

Other major holders of SAVA: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used